MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Patients with a histologically confirmed diagnosis of melanoma (MEL) with unresectable or metastatic disease that have not received ipilimumab (IPI) treatment
3Phase III in Spain, 2Phase II in Spain, 1Phase I